Found: 69
Select item for more details and to access through your institution.
Testosterone Therapy in Men With Hypogonadism Prevents Progression From Prediabetes to Type 2 Diabetes: Eight-Year Data From a Registry Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Androgen therapy in men with testosterone deficiency: can testosterone reduce the risk of cardiovascular disease?
- Published in:
- Diabetes/Metabolism Research & Reviews, 2012, v. 28, p. 52, doi. 10.1002/dmrr.2354
- By:
- Publication type:
- Article
Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss.
- Published in:
- Obesity (19307381), 2013, v. 21, n. 10, p. 1975, doi. 10.1002/oby.20407
- By:
- Publication type:
- Article
Elderly men over 65 years of age with late-onset hypogonadism benefit as much from testosterone treatment as do younger men.
- Published in:
- Korean Journal of Urology, 2015, v. 56, n. 4, p. 310, doi. 10.4111/kju.2015.56.4.310
- By:
- Publication type:
- Article
The Role of Testosterone in the Etiology and Treatment of Obesity, the Metabolic Syndrome, and Diabetes Mellitus Type 2.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
The Role of Testosterone in the Etiology and Treatment of Obesity, the Metabolic Syndrome, and Diabetes Mellitus Type 2.
- Published in:
- Journal of Obesity, 2011, v. 2011, p. 1, doi. 10.1155/2011/471584
- By:
- Publication type:
- Article
High frequency spectral features of galactic cosmic rays at different rigidities during the ascending and maximum phases of the solar cycle 24.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Influence of Agricultural Wastes and Incubation Period on Aggregate Stability in Sandy Soil.
- Published in:
- Alexandria Science Exchange Journal, 2016, v. 37, n. 3, p. 385, doi. 10.21608/asejaiqjsae.2016.2504
- By:
- Publication type:
- Article
Effects of testosterone on erectile function: implications for the therapy of erectile dysfunction.
- Published in:
- BJU International, 2007, v. 99, n. 5, p. 988, doi. 10.1111/j.1464-410X.2007.06756.x
- By:
- Publication type:
- Article
Testosterone Deficiency and Testosterone Treatment in Older Men.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Hypogonadal men with moderate-to-severe lower urinary tract symptoms have a more severe cardiometabolic risk profile and benefit more from testosterone therapy than men with mild lower urinary tract symptoms.
- Published in:
- Investigative & Clinical Urology, 2018, v. 59, n. 6, p. 399, doi. 10.4111/icu.2018.59.6.399
- By:
- Publication type:
- Article
Mechanisms underlying the metabolic actions of testosterone in humans: A narrative review.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 18, doi. 10.1111/dom.14206
- By:
- Publication type:
- Article
Remission of type 2 diabetes following long-term treatment with injectable testosterone undecanoate in patients with hypogonadism and type 2 diabetes: 11-year data from a real-world registry study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2055, doi. 10.1111/dom.14122
- By:
- Publication type:
- Article
Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis.
- Published in:
- European Journal of Endocrinology, 2013, v. 168, n. 6, p. 829, doi. 10.1530/EJE-12-0955
- By:
- Publication type:
- Article
Onset of effects of testosterone treatment and time span until maximum effects are achieved.
- Published in:
- European Journal of Endocrinology, 2011, v. 165, n. 5, p. 675, doi. 10.1530/EJE-11-0221
- By:
- Publication type:
- Article
The Aging Males' Symptoms (AMS) scale: review of its methodological characteristics.
- Published in:
- Health & Quality of Life Outcomes, 2003, v. 1, p. 77, doi. 10.1186/1477-7525-1-77
- By:
- Publication type:
- Article
The Aging Males' Symptoms (AMS) scale: Update and compilation of international versions.
- Published in:
- Health & Quality of Life Outcomes, 2003, v. 1, p. 15, doi. 10.1186/1477-7525-1-15
- By:
- Publication type:
- Article
Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study.
- Published in:
- Clinical Endocrinology, 2011, v. 75, n. 2, p. 275, doi. 10.1111/j.1365-2265.2011.04105.x
- By:
- Publication type:
- Article
Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study.
- Published in:
- Clinical Endocrinology, 2010, v. 73, n. 5, p. 602, doi. 10.1111/j.1365-2265.2010.03845.x
- By:
- Publication type:
- Article
Endoscopic Coblation versus Cold Curettage Adenoidectomy.
- Published in:
- QJM: An International Journal of Medicine, 2021, v. 114, p. i111, doi. 10.1093/qjmed/hcab094.006
- By:
- Publication type:
- Article
298-OR: Lipid Pattern in Men with Hypogonadism and Type 2 Diabetes Improves during Long-Term Treatment with Testosterone Undecanoate Injections (TU) in Comparison with an Untreated Control Group: Update of Real-World Registry Data.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-298-OR
- By:
- Publication type:
- Article
240-OR: Mortality, MACE, and Diabetic Complications in Men with Hypogonadism and Type 2 Diabetes (T2DM) Receiving Long-Term Treatment with Testosterone Undecanoate Injections (TU): An Update of 12-Year Real-World Data.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-240-OR
- By:
- Publication type:
- Article
238-OR: Treatment with Testosterone Undecanoate Injections (TU) Up to 12 Years Improves Glycemic Control in Patients with Hypogonadism and Type 2 Diabetes (T2DM): Update of Real-World Data with 3,149 Patient-Years.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-238-OR
- By:
- Publication type:
- Article
1220-P: Treatment with Testosterone Undecanoate Injections (TU) Results in Sustained Weight Loss in Men with Hypogonadism and Type 2 Diabetes: Update of Real-World Data from a Urological Practice.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-1220-P
- By:
- Publication type:
- Article
758-P: Treatment with Testosterone Undecanoate Injections (TU) Improves Estimated Glomerular Filtration Rate (eGFR) in Men with Hypogonadism and Type 2 Diabetes Mellitus: Update of Real-World Data.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-758-P
- By:
- Publication type:
- Article
136-OR: Lipid Profile in Men with Hypogonadism and Type 2 Diabetes Improves during Long-Term Treatment with Testosterone Undecanoate Injections (TU) in Comparison to an Untreated Control Group: Update of Real-World Registry Data.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-136-OR
- By:
- Publication type:
- Article
401-P: Mortality, Major Adverse Cardiovascular Events (MACDE), and Diabetic Complications in Men with Hypogonadism and Type 2 Diabetes (T2DM) Receiving Long-Term Treatment with Testosterone Undecanoate Injections (TU): 11-Year Real-World Data.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-401-P
- By:
- Publication type:
- Article
2004-P: Treatment with Testosterone Undecanoate Injections (TU) Results in Marked Weight Loss That Is Maintained Long Term in Men with Hypogonadism and Type 2 Diabetes (T2DM): Update of Real-World Data from a Urological Practice.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-2004-P
- By:
- Publication type:
- Article
1075-P: Long-Term Treatment with Testosterone Undecanoate Injections (TU) Improves Glycemic Control in Patients with Hypogonadism and Type 2 Diabetes (T2DM): Update of Real-World Data with 2,928 Patient-Years.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1075-P
- By:
- Publication type:
- Article
1058-P: Effects of Treatment with Testosterone Undecanoate Injections (TU) on Estimated Glomerular Filtration Rate (eGFR) in Men with Hypogonadism and Type 2 Diabetes Mellitus (T2DM) Compared with an Untreated Control Group: Real-World Data.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1058-P
- By:
- Publication type:
- Article
1057-P: Long-Term Testosterone Therapy Results in Remission of Type 2 Diabetes (T2DM) in 34.3% (61 of 178) Men with Hypogonadism and T2DM in a Real-World Registry Study.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1057-P
- By:
- Publication type:
- Article
178-OR: Long-Term Treatment with Injectable Testosterone Undecanoate (TU) Improves Lipid Profile in Men with Hypogonadism and Type 2 Diabetes in Comparison to an Untreated Control Group: Ten-Year Data from a Urological Registry Study.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-178-OR
- By:
- Publication type:
- Article
1137-P: Remission of Type 2 Diabetes (T2DM) in 33.6% (51 of 152) Hypogonadal Men Receiving Long-Term Testosterone Therapy for Up to 12 Years in a Real-Life Registry Study.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1137-P
- By:
- Publication type:
- Article
1124-P: Beneficial Changes in Glycemic Control in Patients with Hypogonadism and Type 2 Diabetes (T2DM) Receiving Long-Term Treatment with Injectable Testosterone Undecanoate (TU): Ten-Year Data from a Registry.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1124-P
- By:
- Publication type:
- Article
1123-P: Reduction of Mortality and Major Adverse Cardiovascular Events (MACE) in Men with Hypogonadism and Type 2 Diabetes (T2DM) Receiving Long-Term Treatment with Injectable Testosterone Undecanoate (TU): Ten-Year Data from a Urological Registry Study.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1123-P
- By:
- Publication type:
- Article
2084-P: Sustained Weight Loss in Men with Hypogonadism and Type 2 Diabetes (T2DM) Receiving Long-Term Treatment with Injectable Testosterone Undecanoate (TU): Ten-Year Data from a Urological Registry Study.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-2084-P
- By:
- Publication type:
- Article
Remission of type 2 diabetes and pleiotropic effects of long-term testosterone treatment for "late-onset" hypogonadism: A case report.
- Published in:
- SAGE Open Medical Case Reports, 2019, v. 7, p. N.PAG, doi. 10.1177/2050313X18823454
- By:
- Publication type:
- Article
Testosterone Deficiency, Long-Term Testosterone Therapy, and Inflammation.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Long-Term Testosterone Therapy Improves Cardiometabolic Function and Reduces Risk of Cardiovascular Disease in Men with Hypogonadism: A Real-Life Observational Registry Study Setting Comparing Treated and Untreated (Control) Groups.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Do Androgens Modulate the Pathophysiological Pathways of Inflammation? Appraising the Contemporary Evidence.
- Published in:
- Journal of Clinical Medicine, 2018, v. 7, n. 12, p. 549, doi. 10.3390/jcm7120549
- By:
- Publication type:
- Article
Sexual motivation: problem solved and new problems introduced.
- Published in:
- Hormone Molecular Biology & Clinical Investigation, 2020, v. 41, n. 2, p. 1, doi. 10.1515/hmbci-2019-0055
- By:
- Publication type:
- Article
Testosterone therapy in men with Crohn's disease improves the clinical course of the disease: data from long-term observational registry study.
- Published in:
- Hormone Molecular Biology & Clinical Investigation, 2015, v. 22, n. 3, p. 111, doi. 10.1515/hmbci-2015-0014
- By:
- Publication type:
- Article
Hormones in normal and pathological prostate.
- Published in:
- Hormone Molecular Biology & Clinical Investigation, 2012, v. 11, n. 3, p. 315, doi. 10.1515/hmbci-2012-0033
- By:
- Publication type:
- Article
Hormones in normal and pathological prostate.
- Published in:
- Hormone Molecular Biology & Clinical Investigation, 2012, v. 11, n. 1, p. 315, doi. 10.1515/hmbci-2012-0033
- By:
- Publication type:
- Article
Age, obesity and inflammation at baseline predict the effects of testosterone administration on the metabolic syndrome.
- Published in:
- Hormone Molecular Biology & Clinical Investigation, 2011, v. 6, n. 1, p. 193, doi. 10.1515/HMBCI.2010.081
- By:
- Publication type:
- Article
The relationship between testosterone deficiency and frailty in elderly men.
- Published in:
- Hormone Molecular Biology & Clinical Investigation, 2010, v. 4, n. 1, p. 529, doi. 10.1515/HMBCI.2010.060
- By:
- Publication type:
- Article
Administration of testosterone to elderly hypogonadal men with Crohn's disease improves their Crohn's Disease Activity Index: a pilot study.
- Published in:
- Hormone Molecular Biology & Clinical Investigation, 2010, v. 2, n. 3, p. 287, doi. 10.1515/HMBCI.2010.033
- By:
- Publication type:
- Article
Beneficial effects of 2 years of administration of parenteral testosterone undecanoate on the metabolic syndrome and on non-alcoholic liver steatosis and C-reactive protein.
- Published in:
- Hormone Molecular Biology & Clinical Investigation, 2010, v. 1, n. 1, p. 27, doi. 10.1515/HMBCI.2010.002
- By:
- Publication type:
- Article
Effects of Long-Term Testosterone Therapy on Patients with "Diabesity": Results of Observational Studies of Pooled Analyses in Obese Hypogonadal Men with Type 2 Diabetes.
- Published in:
- International Journal of Endocrinology, 2014, p. 1, doi. 10.1155/2014/683515
- By:
- Publication type:
- Article
Progressive Improvement of T-Scores in Men with Osteoporosis and Subnormal Serum Testosterone Levels upon Treatment with Testosterone over Six Years.
- Published in:
- International Journal of Endocrinology, 2014, p. 1, doi. 10.1155/2014/496948
- By:
- Publication type:
- Article